|
Volumn 3, Issue 3 Supplement, 1993, Pages 17-19
|
Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women
a b |
Author keywords
Alendronate; Bisphosphonates; Menopause; Osteoporosis
|
Indexed keywords
ALENDRONIC ACID;
BIOCHEMICAL MARKER;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
CALCIUM PHOSPHATE;
OSTEOCALCIN;
PARATHYROID HORMONE;
PYRIDINOL;
ADULT;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BONE REMODELING;
BONE TURNOVER;
CALCIUM URINE LEVEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FEMALE;
HUMAN;
LUMBAR SPINE;
MAJOR CLINICAL STUDY;
ORAL DRUG ADMINISTRATION;
PARATHYROID HORMONE BLOOD LEVEL;
POSTMENOPAUSE;
ALENDRONATE;
BONE DENSITY;
BONE DEVELOPMENT;
BONE RESORPTION;
DIPHOSPHONATES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMAN;
MIDDLE AGE;
OSTEOPOROSIS;
POSTMENOPAUSE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0027421875
PISSN: 0937941X
EISSN: 14332965
Source Type: Journal
DOI: 10.1007/BF01623003 Document Type: Article |
Times cited : (25)
|
References (5)
|